Sight Sciences annual free cash flow
2020
2021
2022
2023
2024
2025
Sight Sciences Free Cash Flow (FCF) History (SGHT)
Sight Sciences reported −$29.9M in free cash flow for fiscal 2025, a decrease of $7.2M from the previous fiscal year, with a free cash flow margin of −38.67%.
View full Sight Sciences company overviewSight Sciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$29.9M | −$7.2M | — | −38.67% |
| 2024 | 2024-12-31 | −$22.7M | $25.2M | — | −28.47% |
| 2023 | 2023-12-31 | −$48.0M | $29.0M | — | −59.19% |
| 2022 | 2022-12-31 | −$76.9M | −$23.6M | — | −107.86% |
| 2021 | 2021-12-31 | −$53.4M | −$20.2M | — | −108.98% |
| 2020 | 2020-12-31 | −$33.1M | — | — | −119.85% |
Sight Sciences quarterly free cash flow
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$5.7M | $2.1M | — | −24.29% |
| Q1 2026 | 2026-03-31 | −$7.1M | $4.5M | — | −35.99% |
| Q4 2025 | 2025-12-31 | −$2.0M | $1.6M | — | −9.73% |
| Q3 2025 | 2025-09-30 | −$8.9M | −$9.2M | — | −44.65% |
| Q2 2025 | 2025-06-30 | −$7.8M | $1.8M | — | −39.63% |
| Q1 2025 | 2025-03-31 | −$11.6M | −$1.7M | — | −66.28% |
| Q4 2024 | 2024-12-31 | −$3.6M | $3.2M | — | −18.85% |
| Q3 2024 | 2024-09-30 | $311,000 | $10.4M | — | +1.54% |
| Q2 2024 | 2024-06-30 | −$9.5M | $4.0M | — | −44.68% |
| Q1 2024 | 2024-03-31 | −$9.9M | $7.6M | — | −51.40% |
| Q4 2023 | 2023-12-31 | −$6.7M | $8.9M | — | −35.99% |
| Q3 2023 | 2023-09-30 | −$10.1M | $10.3M | — | −50.64% |
| Q2 2023 | 2023-06-30 | −$13.6M | $5.1M | — | −57.88% |
| Q1 2023 | 2023-03-31 | −$17.5M | $4.7M | — | −93.01% |
| Q4 2022 | 2022-12-31 | −$15.6M | −$4.8M | — | −76.09% |
| Q3 2022 | 2022-09-30 | −$20.5M | −$3.7M | — | −109.57% |
| Q2 2022 | 2022-06-30 | −$18.6M | −$5.9M | — | −108.23% |
| Q1 2022 | 2022-03-31 | −$22.2M | −$9.2M | — | −149.14% |
| Q4 2021 | 2021-12-31 | −$10.9M | −$2.1M | — | −74.08% |
| Q3 2021 | 2021-09-30 | −$16.8M | — | — | −128.23% |
| Q2 2021 | 2021-06-30 | −$12.7M | — | — | −101.32% |
| Q1 2021 | 2021-03-31 | −$13.0M | — | — | −150.25% |
| Q3 2020 | 2020-09-30 | −$8.7M | — | — | −100.96% |
Sight Sciences free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$33.1M to −$29.9M, a net increase of $3.2M. Sight Sciences's latest reported quarter, Q2 2026, generated −$5.7M in free cash flow, an increase of $2.1M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Sight Sciences filings at SEC.gov ↗